AURORA CANNABIS INC - stock earnings
ACB.TO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -24.5 million CAD | 64.4 million CAD |
| 2023Q3 | -523000 CAD | 63.4 million CAD |
| 2023Q2 | -26.9 million CAD | 75.1 million CAD |
| 2023Q1 | -82.0 million CAD | 64.0 million CAD |
| 2022Q4 | -67.2 million CAD | 61.7 million CAD |
| 2022Q3 | -51.9 million CAD | 49.3 million CAD |
| 2022Q2 | -618.8 million CAD | 50.2 million CAD |
| 2022Q1 | -1.0 billion CAD | 50.4 million CAD |
| 2021Q4 | -75.1 million CAD | 60.6 million CAD |
| 2021Q3 | -11.9 million CAD | 60.1 million CAD |
| 2021Q2 | -128.1 million CAD | 54.6 million CAD |
| 2021Q1 | -164.7 million CAD | 55.2 million CAD |
| 2020Q4 | -292.8 million CAD | 67.7 million CAD |
| 2020Q3 | -108.1 million CAD | 67.8 million CAD |
| 2020Q2 | -1.9 billion CAD | 72.1 million CAD |
| 2020Q1 | -137.4 million CAD | 75.5 million CAD |
| 2019Q4 | -1.3 billion CAD | 56.0 million CAD |
| 2019Q3 | 12.8 million CAD | 75.2 million CAD |
| 2019Q2 | -193000 CAD | 98.9 million CAD |
| 2019Q1 | -158.4 million CAD | 65.1 million CAD |
| 2018Q4 | -237.8 million CAD | 54.2 million CAD |
| 2018Q3 | 105.5 million CAD | 29.7 million CAD |
| 2018Q2 | 79.9 million CAD | 19.1 million CAD |
| 2018Q1 | -19.2 million CAD | 16.1 million CAD |
| 2017Q4 | 7.7 million CAD | 11.7 million CAD |
| 2017Q3 | 3.6 million CAD | 8.2 million CAD |
| 2017Q2 | -4.8 million CAD | 5.9 million CAD |
| 2017Q1 | 138834 CAD | 5.2 million CAD |
| 2016Q4 | -2.7 million CAD | 3.9 million CAD |
| 2016Q3 | -5.6 million CAD | 3.1 million CAD |
| 2016Q2 | -7.5 million CAD | 1.2 million CAD |
| 2016Q1 | 2.5 million CAD | 219230 CAD |
| 2015Q4 | 592927 CAD | ? CAD |
| 2015Q3 | -1.4 million CAD | ? CAD |
| 2015Q2 | 29.2 million CAD | -18500 CAD |
| 2015Q1 | -773178 CAD | ? CAD |
| 2014Q4 | -6.3 million CAD | ? CAD |
| 2014Q3 | -508295 CAD | ? CAD |
| 2014Q2 | -237897 CAD | ? CAD |
| 2014Q1 | -92963 CAD | ? CAD |
| 2013Q4 | -29100 CAD | ? CAD |
| 2013Q3 | -39745 CAD | ? CAD |
| 2013Q2 | -105414 CAD | ? CAD |
| 2013Q1 | -73054 CAD | ? CAD |
| 2012Q4 | -68105 CAD | ? CAD |
| 2012Q3 | -148916 CAD | ? CAD |
| 2012Q2 | -198163 CAD | ? CAD |
| 2012Q1 | -41639 CAD | ? CAD |
| 2011Q4 | -35126 CAD | ? CAD |
| 2011Q3 | -40832 CAD | ? CAD |
| 2011Q2 | -54754 CAD | ? CAD |
| 2011Q1 | -220833 CAD | ? CAD |
| 2010Q4 | -12617 CAD | ? CAD |
| 2010Q3 | -34293 CAD | ? CAD |
| 2010Q2 | -47808 CAD | ? CAD |
| 2010Q1 | -26478 CAD | ? CAD |
| 2009Q4 | -10196 CAD | ? CAD |
| 2009Q3 | -17924 CAD | ? CAD |
| 2009Q2 | -17596 CAD | 40834 CAD |
| 2009Q1 | -29649 CAD | ? CAD |
| 2008Q4 | -22319 CAD | ? CAD |
| 2008Q3 | -76095 CAD | ? CAD |
| 2008Q2 | -22460 CAD | ? CAD |
| 2008Q1 | -4675 CAD | ? CAD |
| 2007Q4 | -150355 CAD | ? CAD |
| 2007Q3 | 204 CAD | ? CAD |
ACB.TO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -199.0 million CAD | 175.0 million CAD |
| 2022 | -1.7 billion CAD | 221.3 million CAD |
| 2021 | -693.5 million CAD | 245.3 million CAD |
| 2020 | -3.3 billion CAD | 278.9 million CAD |
| 2019 | -297.9 million CAD | 247.9 million CAD |
| 2018 | 71.9 million CAD | 55.2 million CAD |
| 2017 | -13.0 million CAD | 18.1 million CAD |
| 2016 | -5.7 million CAD | 1.4 million CAD |
| 2015 | -9.5 million CAD | ? CAD |
| 2014 | -399705 CAD | ? CAD |
| 2013 | -393489 CAD | ? CAD |
| 2012 | -315760 CAD | ? CAD |
| 2011 | -322497 CAD | ? CAD |
| 2010 | -43906 CAD | ? CAD |
| 2009 | -145659 CAD | 40834 CAD |
| 2008 | -177286 CAD | ? CAD |
| 2007 | 1267 CAD | ? CAD |
ACB.TO
Price: CA$9.20
52 week price:
Earnings Per Share: -79.20 CAD
P/E Ratio: -0.07
Exchange: TOR
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 2.0 million
Market Capitalization: 495.2 million